News

ALGRX 3268 is a fast-acting local anesthetic administered into the skin by powder injection and aimed at reducing pain associated with venipuncture procedures such as blood draws and

A research group at the New York University (NYU) School of Medicine have demonstrated that a relatively inexpensive and easy-to-use tool, the electroencephalograph (EEG), can be used to

The orphan drug act guarantees market exclusivity for seven years to the first sponsor that obtains market approval for an orphan-designated product. ZymoGenetics is testing Interleukin 21 (IL-21)

The stem cell niche is a highly specialized microenvironment which surrounds adult stem cells. These niches are key regulators of stem cell activity in mammary tissue. New research

Using an animal model scientists at the Ecole Polytechnique Federale de Lausanne (EPFL) have demonstrated that these holoclones can be used for long-term follicle renewal. The researchers isolated

In addition, the company expects to bring forward into clinical development in 2006 an investigational drug candidate for cystic fibrosis. Vertex’s updated focus on accelerating the clinical development

In January of this year, the company submitted a complete response to a previous approvable letter from the FDA for Zelapar following the successful completion of two safety

“This agreement demonstrates the power of genetics in the drug discovery and development process,” said Greg Yap, vice president of DNA Products at Affymetrix. “We anticipate that a

In 2002, Humira was approved to treat patients with moderately to severely active rheumatoid arthritis (RA), who have had insufficient response to one or more disease-modifying anti-rheumatic drugs.